Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)
More News related to ABT
- Goldman Sachs Removed Abbott Labs (ABT) From Buy List, Eli Lilly (LLY) From Sell List
- Abbot Labs (ABT) To Transfer TriCor Rights to Teva Pharma (TEVA) as Soon as 2011
- Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney & a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies
- Abbott (ABT) sues Teva (TEVA) over its drug for kidney patients, Zemplar
- The Deal Names Abbott Top Dealmaker for Second Consecutive Year
More News related to JNJ
- Emerging Healthcare Launches Health Initiative
- ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
- Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
More News related to Corporate News
- Deutsche Bank Starts Coverage on Utilities Stocks: CMS, AEP, EIX, ITC, PSEG at Buy
- Keefe, Bruyette and Woods Initiates Coverage of Taubman Centers (TCO) with an Outperform
- Keefe, Bruyette and Woods Initiates Coverage of Simon Property Group (SPG) with an Outperform
- Keefe, Bruyette and Woods Initiates Coverage of Tanger Factory Outlet Centers (SKT) with a Market Perform
- Keefe, Bruyette and Woods Initiates Coverage of Pennsylvania REIT (PEI) with a Market Perform
Centocor Ortho Biotech Inc., wholly-owned subsidiary of Johnson & Johnson (NYSE: JNJ), announced that a federal jury has returned a verdict of $1.67 billion against Abbott Laboratories (NYSE: ABT) in a patent infringement suit.
The patent in question relates to the company's anti-TNF class of arthritis treatments, and is co-owned by New York University and Centocor, for which Centocor is the exclusive licensee.
Related Categories
Corporate NewsHot List
Stocks Mentioned
-0.01
+0.67Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
